These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26566390)

  • 1. Community-based ART distribution system can effectively facilitate long-term program retention and low-rates of death and virologic failure in rural Uganda.
    Okoboi S; Ding E; Persuad S; Wangisi J; Birungi J; Shurgold S; Kato D; Nyonyintono M; Egessa A; Bakanda C; Munderi P; Kaleebu P; Moore DM
    AIDS Res Ther; 2015; 12():37. PubMed ID: 26566390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
    Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study.
    Nyakato P; Schomaker M; Fatti G; Tanser F; Euvrard J; Sipambo N; Fox MP; Haas AD; Yiannoutsos CT; Davies MA; Cornell M
    J Int AIDS Soc; 2022 Jan; 25(1):e25870. PubMed ID: 35032096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender disparities operate in opposite directions for hospitalizations and mortality among individuals receiving long-term ART in rural Uganda.
    Massah G; Zhang W; Birungi J; Nanfuka M; Zhu J; Okoboi S; Kaleebu P; Tibenganas B; Moore DM
    HIV Med; 2021 Jul; 22(6):512-518. PubMed ID: 33730434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda.
    Castelnuovo B; Kiragga A; Musaazi J; Sempa J; Mubiru F; Wanyama J; Wandera B; Kamya MR; Kambugu A
    PLoS One; 2015; 10(12):e0142722. PubMed ID: 26642214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated with Retention to Care in an HIV Clinic in Gabon, Central Africa.
    Janssen S; Wieten RW; Stolp S; Cremers AL; Rossatanga EG; Klipstein-Grobusch K; Belard S; Grobusch MP
    PLoS One; 2015; 10(10):e0140746. PubMed ID: 26473965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study.
    Barnabas RV; van Rooyen H; Tumwesigye E; Murnane PM; Baeten JM; Humphries H; Turyamureeba B; Joseph P; Krows M; Hughes JP; Celum C
    Lancet HIV; 2014 Nov; 1(2):e68-e76. PubMed ID: 25601912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
    Grimsrud A; Kaplan R; Bekker LG; Myer L
    Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liberia adherence and loss-to-follow-up in HIV and AIDS care and treatment: A retrospective cohort of adolescents and adults from 2016-2019.
    Gray KL; Kiazolu M; Jones J; Konstantinova A; Zawolo JSW; Gray WH; Walker NF; Garbo JT; Caldwell S; Odo M; Bhadelia N; DeMarco J; Skrip LA
    PLOS Glob Public Health; 2022; 2(3):e0000198. PubMed ID: 36962289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When are patients lost to follow-up in pre-antiretroviral therapy care? a retrospective assessment of patients in an Ethiopian rural hospital.
    Shaweno T; Shaweno D
    Infect Dis Poverty; 2015; 4():27. PubMed ID: 26034602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique.
    Decroo T; Koole O; Remartinez D; dos Santos N; Dezembro S; Jofrisse M; Rasschaert F; Biot M; Laga M
    Trop Med Int Health; 2014 May; 19(5):514-21. PubMed ID: 24898272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?
    Saunders P; Goodman AL; Smith CJ; Marshall N; O'Connor JL; Lampe FC; Johnson MA
    HIV Med; 2016 Jan; 17(1):18-27. PubMed ID: 26140659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.
    Franke MF; Kaigamba F; Socci AR; Hakizamungu M; Patel A; Bagiruwigize E; Niyigena P; Walker KD; Epino H; Binagwaho A; Mukherjee J; Farmer PE; Rich ML
    Clin Infect Dis; 2013 May; 56(9):1319-26. PubMed ID: 23249611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
    McMahon JH; Spelman T; Ford N; Greig J; Mesic A; Ssonko C; Casas EC; O'Brien DP
    AIDS Res Ther; 2016; 13():25. PubMed ID: 27408611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
    Stringer JS; Zulu I; Levy J; Stringer EM; Mwango A; Chi BH; Mtonga V; Reid S; Cantrell RA; Bulterys M; Saag MS; Marlink RG; Mwinga A; Ellerbrock TV; Sinkala M
    JAMA; 2006 Aug; 296(7):782-93. PubMed ID: 16905784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.
    Wilhelmson S; Reepalu A; Balcha TT; Jarso G; Björkman P
    Glob Health Action; 2016; 9():29943. PubMed ID: 26765104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of baseline CD4(+) cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited setting.
    Mills EJ; Bakanda C; Birungi J; Yaya S; Ford N;
    AIDS; 2012 Jul; 26(11):1425-9. PubMed ID: 22526520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
    Tweve EN; Kayabu D; Nassari NO; Todd J
    Trop Med Int Health; 2015 Jun; 20(6):791-6. PubMed ID: 25706518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.